Table of Contents Author Guidelines Submit a Manuscript
International Journal of Hypertension
Volume 2012, Article ID 859176, 4 pages
http://dx.doi.org/10.1155/2012/859176
Review Article

Hypertension in the Elderly

1Service of Internal Medicine, Hypertension and Lipid Unit, “San Cecilio” University Hospital, Granada, Spain
2Department of Medicine, The University of Zaragoza, Zaragoza, Spain

Received 6 April 2011; Accepted 3 July 2011

Academic Editor: Jaako Tuomilehto

Copyright © 2012 Blas Gil-Extremera and Pedro Cía-Gómez. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. B. G. Extremera, J. A. Puertas, A. M. Martín et al., “Factores de riesgo en ancianos. Estudio de 143 pacientes,” Anales de Medicina Interna, vol. 14, no. 10, pp. 495–499, 1997. View at Google Scholar · View at Scopus
  2. J. A. Staessen, R. Fagard, L. Thijs et al., “Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension,” The Lancet, vol. 350, no. 9080, pp. 757–764, 1997. View at Publisher · View at Google Scholar
  3. F. Forette, M. L. Seux, J. A. Staessen et al., “Prevention of dementia in randomised double-blind placebo-controlled systolic hypertension in Europe (syst-eur) trial,” The Lancet, vol. 353, no. 9137, pp. 1347–1351, 1998. View at Publisher · View at Google Scholar · View at Scopus
  4. J. A. Staessen, L. Thijs, R. H. Fagard et al., “Calcium channel blockade and cardiovascular prognosis in the european trial on isolated systolic hypertension,” Journal of Hypertension, vol. 32, no. 3, pp. 410–416, 1998. View at Google Scholar · View at Scopus
  5. L. Thijs, T. Richart, P. W. De Leeuw et al., “Morbidity and mortality on combination versus monotherapy: a posthoc analysis of the systolic hypertension in Europe trial,” Journal of Hypertension, vol. 28, no. 4, pp. 865–874, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  6. F. Forette, M. L. Seux, J. A. Staessen et al., “The prevention of dementia with antihypertensive treatment,” Archives of Internal Medicine, vol. 162, no. 18, pp. 2046–2052, 2002. View at Publisher · View at Google Scholar · View at Scopus
  7. C. J. Bulpitt, A. E. Fletcher, N. Beckett et al., “The hypertension in the very elderly trial (HYVET). Protocol for the main trial,” Drugs and Aging, vol. 18, no. 3, pp. 151–164, 2001. View at Google Scholar · View at Scopus
  8. C. J. Bulpitt, N. S. Beckett, J. Cooke et al., “Results of the pilot study for the hypertension in the very elderly trial,” Journal of Hypertension, vol. 21, no. 12, pp. 2401–2409, 2003. View at Google Scholar · View at Scopus
  9. C. J. Bulpitt, N. S. Beckett, J. Cooke et al., “Results of the pilot study for the hypertension in the very elderly trial,” Journal of Hypertension, vol. 21, no. 12, pp. 2409–2417, 2003. View at Publisher · View at Google Scholar · View at Scopus
  10. N. Beckett, R. Peters, A. Fletcher et al., “Treatment of hypertension in patients 80 years of age or older,” The New England Journal of Medicine, vol. 358, no. 18, pp. 1887–1898, 2008. View at Google Scholar
  11. H. R. Black, W. J. Elliott, J. D. Neaton et al., “Baseline characteristics and early blood pressure control in the CONVINCE trial,” Journal of Hypertension, vol. 37, no. 1, pp. 12–18, 2001. View at Google Scholar · View at Scopus
  12. H. R. Black, W. J. Elliott, G. Grandits et al., “Principal results of the controlled onset verapamil investigation of cardiovascular end points (CONVINCE) trial,” Journal of the American Medical Association, vol. 289, no. 16, pp. 2073–2082, 2003. View at Publisher · View at Google Scholar · View at PubMed
  13. F. J. Morich, F. Bieber, J. M. Lewis et al., “Nimodipine in the treatment of probable Alzheimer's disease: results of two multicentre trials,” Clinical Drug Investigation, vol. 11, no. 4, pp. 185–195, 1996. View at Google Scholar · View at Scopus
  14. R. C. Atienza, B. G. Extremera et al., “Hipertensión arterial y capacidad intelectual,” Hipertensión, vol. 17, no. 5, pp. 216–224, 2000. View at Google Scholar
  15. P. A. Poole-Wilson, J. Lubsen, B. A. Kirwan et al., “Effect of long-acting nifedipine on mortality and cardiovascular morbidity in patients with stable angina requiring treatment (ACTION trial): randomised controlled trial,” The Lancet, vol. 364, no. 9437, pp. 849–857, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus